Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotics

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DRUG

ziprasidone

Ziprasidone by mouth 40mg twice a day (bid) for one day, then 80mg bid; may be increased to 120mg bid after three weeks

Trial Locations (2)

10461

Bronx Psychiatric Center, The Bronx

14213

Buffalo Psychiatric Center, Buffalo

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

collaborator

Buffalo Psychiatric Center

OTHER

collaborator

Rochester Psychiatric Center

OTHER

lead

Bronx Psychiatric Center

OTHER_GOV